David Krempa, Chief Business Officer at Eton Pharmaceuticals, sold ETON on Aug 24, 2026
Data as of Oct 16
▼ SELL$1.6M25,000 shares at $65.07David Krempa Chief Business OfficerETON Eton Pharmaceuticals, Inc.
- Traded
- Aug 24, 2026
- Disclosed
- Aug 24, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ETON since disclosure
−21.9%
after the sale
Similar stocks (XLV) since disclosure
+1.2%
XLV — its sector index fund
Change in closing price from Aug 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.